Literature DB >> 12802892

Bivalent effects of MK-801 on ethanol-induced sensitization do not parallel its effects on ethanol-induced tolerance.

Paul J Meyer1, Tamara J Phillips.   

Abstract

The relationship between the effects of the N-methyl-D-aspartate (NMDA) antagonist MK-801 on acute responses to ethanol and its ability to block ethanol sensitization and tolerance was examined in DBA/2J mice. Cross-sensitization between these drugs was also studied. Repeated administration of 0.1 mg/kg MK-801 with ethanol potentiated, whereas 0.25 mg/kg attenuated, sensitization to ethanol's locomotor stimulant effects; rearing was similarly affected. There was evidence for cross-sensitization between ethanol and 0.25 mg/kg MK-801. MK-801 potentiated ethanol's ataxic effects in the grid test, but had no effect on tolerance to this effect. MK-801's effects on ethanol sensitization appeared to be related to its own behavioral effects, rather than NMDA receptor blockade per se. Further, these studies demonstrate dissociation between ethanol sensitization and tolerance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802892     DOI: 10.1037/0735-7044.117.3.641

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  21 in total

1.  Inhibition of extracellular signal-regulated kinase (ERK) activity with SL327 does not prevent acquisition, expression, and extinction of ethanol-seeking behavior in mice.

Authors:  Peter A Groblewski; Frederick H Franken; Christopher L Cunningham
Journal:  Behav Brain Res       Date:  2010-11-11       Impact factor: 3.332

Review 2.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

3.  Involvement of protein kinase A in ethanol-induced locomotor activity and sensitization.

Authors:  J R Fee; D J Knapp; D R Sparta; G R Breese; M J Picker; T E Thiele
Journal:  Neuroscience       Date:  2006-03-09       Impact factor: 3.590

4.  Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.

Authors:  Paul J Meyer; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2007-07-26       Impact factor: 4.530

5.  Comparison of ethanol locomotor sensitization in adolescent and adult DBA/2J mice.

Authors:  Rebekah A Stevenson; Joyce Besheer; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2007-12-22       Impact factor: 4.530

Review 6.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

7.  Repeated ethanol administration modifies the temporal structure of sucrose intake patterns in mice: effects associated with behavioral sensitization.

Authors:  Raúl Pastor; Helen M Kamens; Carrie S McKinnon; Matthew M Ford; Tamara J Phillips
Journal:  Addict Biol       Date:  2010-07       Impact factor: 4.280

8.  Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site.

Authors:  Lauren Debrouse; Benita Hurd; Carly Kiselycznyk; Aaron Plitt; Alyssa Todaro; Masayoshi Mishina; Seth G N Grant; Marguerite Camp; Ozge Gunduz-Cinar; Andrew Holmes
Journal:  Alcohol Clin Exp Res       Date:  2012-08-30       Impact factor: 3.455

9.  Nicotine enhances the locomotor stimulating but not the conditioned rewarding effect of ethanol in DBA/2J mice.

Authors:  Noah R Gubner; Christopher L Cunningham; Tamara J Phillips
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

10.  Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication.

Authors:  Benjamin Palachick; Yi-Chyan Chen; Abigail J Enoch; Rose-Marie Karlsson; Masayoshi Mishina; Andrew Holmes
Journal:  Alcohol Clin Exp Res       Date:  2008-06-28       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.